Thomas Kislinger - Concepedia

Author

Thomas Kislinger

Also Known As

Kislinger, Thomas, Strahl, Brian D., T Kislinger, T. Kislinger, THOMAS KISLINGER, Thomas Kislinger, Thomas R. Kislinger, Yash Patel

428

Publications

28.2K

Citations

H-Index

190

Concepts

All Affiliations

University of Toronto University Health Network Princess Margaret Cancer Centre Ontario Institute for Cancer Research Hospital for Sick Children

About

Thomas Kislinger is an author at University of Toronto specializing in medicine, cell biology, and proteomics.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	41	65	7.3K
2	Natural Sciences	25	32	2.3K
3	Engineering	7	7	1K
4	Health Sciences	2	2	68
5	Social Sciences	1	1	35

Thomas Kislinger

137

Publications

26K

Citations

H-Index

Page 1

	Year	Citations
Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines Clotilde Théry, Kenneth W. Witwer, Elena Aïkawa, Journal of Extracellular Vesicles	2018	10.7K
Blockade of RAGE–amphoterin signalling suppresses tumour growth and metastases Akihiko Taguchi, David C. Blood, G. Del Toro, Nature MedicineCancer BiologyRadiation OncologyCell SignalingTumor Biology	2000	1.2K
N ε-(Carboxymethyl)Lysine Adducts of Proteins Are Ligands for Receptor for Advanced Glycation End Products That Activate Cell Signaling Pathways and Modulate Gene Expression Thomas Kislinger, Caifeng Fu, Birgit Huber, Journal of Biological Chemistry	1999	860
Characterization of the proteins released from activated platelets leads to localization of novel platelet proteins in human atherosclerotic lesions Judith A. Coppinger, Gerard Cagney, Sinéad Toomey, Blood	2003	809
RAGE Drives the Development of Glomerulosclerosis and Implicates Podocyte Activation in the Pathogenesis of Diabetic Nephropathy Thoralf Wendt, Nozomu Tanji, Jiancheng Guo, American Journal Of Pathology Glomerular DiseaseRenal PathologyImmunologyInflammationGlomerulonephritis	2003	588
RAGE Blockade Stabilizes Established Atherosclerosis in Diabetic Apolipoprotein E–Null Mice Loredana Bucciarelli, Thoralf Wendt, Wu Qu, Circulation	2002	560
Advanced Glycation End Products Activate Endothelium Through Signal-Transduction Receptor RAGE Giuseppina Basta, Guido Lazzerini, Marika Massaro, Circulation	2002	535
Global Survey of Organ and Organelle Protein Expression in Mouse: Combined Proteomic and Transcriptomic Profiling Thomas Kislinger, Brian Cox, Anitha Kannan, Cell BioinformaticsProteomic TechnologySystems BiologyTranscriptomic ProfilingMedicine	2006	491
Expression of Advanced Glycation End Products and Their Cellular Receptor RAGE in Diabetic Nephropathy and Nondiabetic Renal Disease Nozomu Tanji, Glen S. Markowitz, Caifeng Fu, Journal of the American Society of Nephrology	2000	476
Blockade of Receptor for Advanced Glycation End-Products Restores Effective Wound Healing in Diabetic Mice Mouza T. Goova, Jun Li, Thomas Kislinger, American Journal Of Pathology InflammationMedicineDiabetesGlycobiologyDiabetic Mice	2001	426

Page 1